Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126600) titled 'A Multicenter Study of ML-PopPK/PD Strategy for Personalized Tacrolimus in Early Postoperative Infant Liver Transplantation' on June 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Rejection after pediatric liver transplantation
Intervention:
Conventional Dosing Group:PopPK-ML Integrated Model-Guided Dosing
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-12
Target Sample Size: Conventional Dosing Group:100;Model-Guided Dosing Group:100;
Countries of R...